v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 2,241,980 $ 3,559,361
Prepaid expenses and other current assets 196,018 45,263
Deferred offering costs 92,168 117,000
Total current assets 2,530,166 3,721,624
Total assets 2,530,166 3,721,624
Current liabilities    
Accounts payable 770,610 1,089,666
Accrued expenses 1,057,941 1,324,316
Insurance premium financing liability 84,540
Note payable 249,716
Total current liabilities 2,162,807 2,413,982
Total liabilities 2,162,807 2,413,982
Commitments and contingencies (see Note 5)  
Stockholders’ equity    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024
Common stock, $0.0001 par value, 250,000,000 shares authorized, 4,221,166 shares and 1,973,999 shares issued and 4,220,920 shares and 1,973,753 shares outstanding as of June 30, 2025 and December 31, 2024, respectively 422 198
Additional paid-in capital 41,734,853 38,278,503
Accumulated deficit (41,297,951) (36,901,094)
Treasury stock, at cost, 246 shares held in treasury as of June 30, 2025 and December 31, 2024 (69,965) (69,965)
Total stockholders’ equity 367,359 1,307,642
Total liabilities and stockholders’ equity $ 2,530,166 $ 3,721,624